European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1

@article{Jordan2008EuropeanGF,
  title={European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1},
  author={Joe Jordan and Marc Arbyn and Pierre Martin-Hirsch and U. Schenck and Jean Jacques Baldauf and Daniel Pereira da Silva and Ahti Anttila and Pekka Nieminen and Walter J Prendiville},
  journal={Cytopathology},
  year={2008},
  volume={19}
}
The current paper presents the first part of Chapter 6 of the second edition of the European Guidelines for Quality Assurance in Cervical Cancer Screening. It provides guidance on how to manage women with abnormal cervical cytology. Throughout this article the Bethesda system is used for cervical cytology terminology, as the European guidelines have recommended that all systems should at least be translated into that terminology while cervical intraepithelial neoplasia (CIN) is used for… Expand
View on Wiley
onlinelibrary.wiley.com
159 Citations
Highly Influential Citations
6
Background Citations
27
Methods Citations
6

159 Citations

Citation Type

Citation Type

European guidelines for quality assurance in cervical histopathology
TLDR
Guidelines for sampling and processing of cervical tissue specimens obtained by biopsy, excision and/or curettage are proposed. Expand
National guidelines for management of cervical squamous intraepithelial lesion: A survey of European Federation for colposcopy members.
TLDR
Most EFC member countries have appropriate national guidelines for management of cervical SIL that were developed using a clear methodology, are updated according to progresses in the field and are accessible online to current practitioners. Expand
Cytology versus HPV testing for cervical cancer screening in the general population.
TLDR
The quality of the evidence for the sensitivity of the tests was moderate, and high for the specificity, and the results did not differ by age of women (less than or greater than 30 years old), or in studies with verification bias. Expand
High-Grade Cervical Lesions Among Women Attending A Reference Clinic In Brazil: Associated Factors And Comparison Among Screening Methods
TLDR
The results confirm an association of HR-HPV with precursor lesions for cervical cancer and emphasize that cytological screening to detect precursor lesions is still important in some regions and that HR- HPV should be included for screening. Expand
Triage of Women with Low-Grade Cervical Lesions - HPV mRNA Testing versus Repeat Cytology
TLDR
HPV mRNA testing was more sensitive and specific than repeat cytology in triage of women with LSIL cytology and showed higher PPV, indicating that the HPV mRNA test is a better triage test for women with low-grade squamous intraepithelial lesions. Expand
HPV Testing and Vaccination in Europe
TLDR
HPV vaccination will require many years to evaluate any beneficial effects on cervical cancer incidence and mortality and the effects of HPV-based screening depend on the organization of the program and on adherence to algorithms for screening triage. Expand
Recommendations that could improve performance of colposcopy and cytology
  • R. Dina
  • Medicine
  • Cytopathology : official journal of the British Society for Clinical Cytology
  • 2008
TLDR
For the control of post-treatment affected margins, I believe that one should emphasise the value of HPV testing in the sixth month after treatment as its diagnostic value in detecting residual disease is superior to cytology and colposcopy. Expand
The Future Role for Colposcopy in Europe
TLDR
How issues of vaccination against human papillomavirus types 16 and 18 as well as the possible switch to HPV-based screening is likely to change the profiles of women presenting to colposcopy services and provide management difficulties for the colposcopist is considered. Expand
hr-HPV testing in the follow-up of women with cytological abnormalities and negative colposcopy
TLDR
The results confirm that hr-HPV testing is able to select the real group of women at risk of developing CIN2+ lesions in the follow-up of abnormal cytology and first negative colposcopy. Expand
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
TLDR
This review evaluates two ways to triage women with ASCUS or LSIL: repeating the cytological test, and DNA testing for high-risk types of the human papillomavirus (hrHPV) - the main causal factor of cervical cancer. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 102 REFERENCES
European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology
TLDR
The following short annexe to Chapter 3 of the European Guidelines for Quality Assurance in Cervical Cancer Screening provides a framework that will allow different terminologies and languages to be translated into standard terminology based on the Bethesda system for cytology while retaining the cervical intraepithelial neoplasia (CIN) classification for histology. Expand
Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence.
TLDR
HPV testing using the Hybrid Capture II test is more effective (more sensitive, equally specific) than cytology for the triage of patients with ASCUS Pap smears and for predicting recurrence of CIN in women treated for high-grade CIN. Expand
Interim Guidelines for Management of Abnormal Cervical Cytology
TLDR
In recent years it has become evident that the cost and morbidity associated with the detection and treatment of low-grade cervical lesions have escalated, probably increasing the likelihood of women developing cervical cancer. Expand
Comparison of Management Algorithms for the Evaluation of Women With Low‐Grade Cytologic Abnormalities
TLDR
A repeat Papanicolaou smear combined with a HPV DNA test is a sensitive alternative to colposcopic evaluation for the detection of CIN in women referred for a previous low-grade abnormal PAP smear, but because of the low specificity, it results in only modest cost reductions compared to the more standard triage of performing colposcopy at the first visit. Expand
Have we resolved how to triage equivocal cervical cytology?
TLDR
A metaanalysis comparing the performance of two triage strategies following an ASCUS result: repeating a cytology test and HPV DNA testing is reported, helpful in solidifying the understanding of HPVDNA testing and repeat cytology in the triage of equivocal Pap tests and in directing the course of future research. Expand
Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.
TLDR
Sufficient evidence exists to recommend HPV testing in triage of women with atypical cytology and in surveillance after treatment of CIN lesions, and the European screening policy will be reviewed based on the longitudinal results of randomised population trials which are currently underway. Expand
Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.
TLDR
The published literature indicates that the Hybrid Capture II assay has improved accuracy (higher sensitivity, similar specificity) than the repeat Pap smear using the threshold of ASCUS for an outcome of CIN2+ among women with equivocal cytologic results. Expand
The presence of persistent high‐risk hpv genotypes in dysplastic cervical lesions is associated with progressive disease: Natural history up to 36 months
TLDR
The results show that the continuous presence of high‐risk HPV types in women with cytomorphologically abnormal smears is a strong marker for progressive CIN disease. Expand
Comparison of three management strategies for patients with atypical squamous cells of undetermined significance: baseline results from a randomized trial.
TLDR
HC 2 testing for cancer-associated HPV DNA is a viable option in the management of women with ASCUS and has greater sensitivity to detect CIN3 or above and specificity comparable to a single additional cytologic test indicating ASCUS or above. Expand
Management of women who test positive for high-risk types of human papillomavirus: the HART study
TLDR
Comparison of the detection rate and positive predictive values of HPV assay with cytology and the best management strategy for HPV-positive women found HPV testing was more sensitive than borderline or worse cytology but less specific for detecting CIN2+. Expand
...
1
2
3
4
5
...